[
  {
    "filename": "HIV-HIV-2018-Molloy-A-randomised-controlled-trial-of.pdf",
    "success": true,
    "coverage": 0.0,
    "populated_fields": 0,
    "total_fields": 9,
    "confidence": 0.0,
    "total_pages": 181,
    "raw_sections": 0,
    "tables": 0,
    "field_details": [
      {
        "field": "study_overview",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "brief_description",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "primary_secondary_objectives",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "treatment_arms_interventions",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "eligibility_criteria",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "enrollment_participant_flow",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "adverse_events_profile",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "study_locations",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "sponsor_information",
        "populated": false,
        "length": 0,
        "preview": ""
      }
    ]
  },
  {
    "filename": "HIV-HIV-2019-Venter-ADVANCE.pdf",
    "success": true,
    "coverage": 88.88888888888889,
    "populated_fields": 8,
    "total_fields": 9,
    "confidence": 0.5555555555555556,
    "total_pages": 183,
    "raw_sections": 0,
    "tables": 177,
    "field_details": [
      {
        "field": "study_overview",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "brief_description",
        "populated": true,
        "length": 18854,
        "preview": "1.1 Background Information                                                            Significant ga"
      },
      {
        "field": "primary_secondary_objectives",
        "populated": true,
        "length": 4562,
        "preview": "Baseline    Visit Follow-up Visits: 2,                    Study Visit                               "
      },
      {
        "field": "treatment_arms_interventions",
        "populated": true,
        "length": 600,
        "preview": "in low-           and middle-income countries (LMIC) through the support of local governments, inter"
      },
      {
        "field": "eligibility_criteria",
        "populated": true,
        "length": 45,
        "preview": "2. Inclusion/exclusion criteria determination"
      },
      {
        "field": "enrollment_participant_flow",
        "populated": true,
        "length": 204,
        "preview": "15. Study medications dispensing, patient education on adherence and accountability                 "
      },
      {
        "field": "adverse_events_profile",
        "populated": true,
        "length": 189,
        "preview": "Page 22                     Wits Reproductive Health and HIV Institute                              "
      },
      {
        "field": "study_locations",
        "populated": true,
        "length": 185,
        "preview": "10. History or presence of allergy to the study drugs or their components.            5.0 Study Proc"
      },
      {
        "field": "sponsor_information",
        "populated": true,
        "length": 600,
        "preview": "                                     Significant gains have been made in the last decade in terms of"
      }
    ]
  },
  {
    "filename": "Prot_000.pdf",
    "success": true,
    "coverage": 22.22222222222222,
    "populated_fields": 2,
    "total_fields": 9,
    "confidence": 0.15151515151515152,
    "total_pages": 233,
    "raw_sections": 0,
    "tables": 54,
    "field_details": [
      {
        "field": "study_overview",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "brief_description",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "primary_secondary_objectives",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "treatment_arms_interventions",
        "populated": true,
        "length": 2256,
        "preview": "4 weeks prior to first dose of study drug if radiotherapy was to                                 the"
      },
      {
        "field": "eligibility_criteria",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "enrollment_participant_flow",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "adverse_events_profile",
        "populated": true,
        "length": 335013,
        "preview": "dosingor until the start of subsequent anti-                                                        "
      },
      {
        "field": "study_locations",
        "populated": false,
        "length": 0,
        "preview": ""
      },
      {
        "field": "sponsor_information",
        "populated": false,
        "length": 0,
        "preview": ""
      }
    ]
  }
]